-
Roivant and iNtRON sign licensing deal for SAL200
pharmaceutical
November 21, 2018
Roivant Sciences and iNtRON Biotechnology have signed a $667.5m global licensing agreement for SAL200, which is an investigational biologic to treat infectious diseases caused by antibiotic-resistant staphylococci.
-
UK government accused of using Brexit to avoid antimicrobial resistance ruling
pharmafile
September 29, 2018
The British government has been accused of using Brexit to avoid implementing new EU legislation preventing powerful antibiotics from be used in farming.
-
Regeneron Pharma and Bluebird bio announce immune cell collaboration
pharmafile
August 08, 2018
Regeneron Pharmaceuticals have announced that they will collaborate with the Massachusetts-based gene therapy specialist Bluebird bio in an effort to develop and commercialise novel immune cell therapies for cancer.
-
Gov’t launches £10 antimicrobial research competition
pharmatimes
July 16, 2018
The government has launched a £10 million research competition to encourage the development of novel approaches to combating antimicrobial resistance and improving infection prevention and control.
-
Researchers propose key elements of antimicrobial stewardship for hospitals worldwide
worldpharmanews
April 09, 2018
Antimicrobial stewardship programs (ASPs) in hospitals play a vital role in managing the threat of antibiotic resistance
-
ICMR, Pfizer to work on antimicrobial resistance
expressbpd
February 01, 2018
The Indian Council of Medical Research (ICMR) and Pfizer has announced that they will set up a centre to address the growing threat of antimicrobial resistance in India.
-
Keneric Healthcare and Angelini Pharma Partner in the U.S. Wound Care Market
firstwordpharma
January 25, 2017
Keneric Healthcare, a medical device company that offers innovative and cost effective patient care products, today announced their partnership with Angelini Pharma Inc.